There is an interesting change of a notation in the recent announcement of an approval (the approval, itself, is not a big deal as it is only a $10 million product, and hitk would be lucky to get more than $1 million in sales out of it).
Hitk says that it has 13 pending fda applications targeting $1.5 billion in sales, with 20 products in development target over $3 billion in sales. The most recent previous statements said 13 applications only approximately $1.0 and $4.0 (about a year ago it was $1.0 and $3.0).
That means that they have added one product that produces at least $500 million to the actual applications. Maybe one or two that they were developing got dropped (accounting for the drop from 4 to 3) or the one that has been moved to the application side really is more than 500 million and the $ 4 billion was a little optimisitic (or a combination of all).
Actually, to see a $500 million product move to the application side is a very nice development. This company is about products. A $500+ million product could generate nice sales of 50 - 100 million for hitk.